MYRA PIERATT: Open Payments
NPI 1396700308 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,590 in 79 payments from 22 companies in 2025. Trend: 2023 $1,295 · 2024 $1,285 · 2025 $1,590
Food & beverage: $1,590
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $412 |
| ABBVIE INC. | 16 | $225 |
| Novo Nordisk Inc | 6 | $158 |
| GlaxoSmithKline, LLC. | 6 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $85 |
| Lilly USA, LLC | 4 | $72 |
| Amgen Inc. | 3 | $44 |
| PFIZER INC. | 2 | $42 |
| SANOFI-AVENTIS U.S. LLC | 2 | $36 |
Products named: AIRSUPRA, FARXIGA, QULIPTA, Ozempic, Kerendia, TRELEGY ELLIPTA, CAPLYTA, MOUNJARO.
Industry payments across KY — which companies pay providers there.
